
Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines
Keywords: Monoclonal antibodies; HD37; RFB4; Anti-CD19; Anti-CD22; Pre-B ALL; Immunotherapy; Chemotherapy; Childhood leukemia; Vincristine; Daunorubicin